Mexican propolis |
Canine distemper virus |
In vitro African green monkey kidney cells |
Propolis application decreased viral expression and correlated with increased cell viability. |
[110] |
Propolis extracts |
HSV-1 |
In vitro RC-37 cells |
IC50 values of aqueous and ethanol extracts were determined at 0.0004% and 0.000035%, respectively. |
[111] |
Propolis |
HIV-1 |
In vitro |
Propolis abolished syncytium formation at 4.5 micrograms/mL and decreased p24 antigen production by as much as 90–100%. |
[112] |
Propolis extracts |
HSV-1 and HSV-2 |
In vitro |
Standardized preparations of propolis exhibited antiviral bioactivity. |
[26] |
Brazilian propolis (kaempferol, KF and p-coumaric acid, and p-CA) |
Human rhinoviruses (HRVs) |
In vitro HeLa cells |
They inhibited HRV-3 infection when added during the early stages following virus inoculation. |
[113] |
Propolis |
HSV-1 |
In vitro Vero cells in vivo newborn rats |
The addition of 10% propolis extract led to 80–85% protection. |
[114] |
Propolis extract GH-2002 |
Varicella zoster virus |
In vitro LEP cells |
IC50 value was determined to be 64 μg/mL. |
[115] |
Propolis extract ACF®
|
HSV-1 and HSV-2 |
In vitro MDBK cells |
Showed pronounced virucidal effect and interfered with virus adsorption. |
[116] |